01666.HK
Tong Ren Tang Technologies Co. Ltd.
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 2.99
+2.58%Year over year
Reported trailing growth
- Revenue
- -17.0%
- EBITDA
- -19.2%
- EBIT
- -28.3%
- EPS
- -29.3%
- Free cash flow
- -20.0%
- Operating cash flow
- -21.5%
Forward estimates
Based on analyst estimates
- Revenue
- -49.6%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +2.7%
- EBITDA
- -8.3%
- EBIT
- -12.9%
- Net income
- -12.1%
- EPS
- -12.3%
- Free cash flow
- +36.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026